Login Register Cart 0
Generic placeholder image

Current Drug Research Reviews

Editor-in-Chief

ISSN (Print): 2589-9775
ISSN (Online): 2589-9783

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Research Article

Development and Validation of RP-HPLC Method for the Estimation of Tenofovir and Emtricitabine in Bulk and Pharmaceutical Dosage Form

Author(s): Biswa Mohan Sahoo*, Pallepogu Venkateswara Rao and Naidu Srinivasa Rao

Volume 16, Issue 1, 2024

Published on: 08 June, 2023

Page: [73 - 80] Pages: 8

DOI: 10.2174/2589977515666230602151222

Price: $65

Abstract

Background: A novel, simple, efficient, rapid, and precise reverse-phase highperformance liquid chromatography (RP-HPLC) method was developed for the estimation of Tenofovir and Emtricitabine in the bulk and pharmaceutical dosage form. The currently developed method was subsequently validated according to ICH guidelines in terms of linearity, accuracy, precision, the limit of detection, the limit of quantification, robustness, etc.

Methods: The separation of the selected drugs was optimized after several trials including change of mobile phase and its composition, stationary phase, flow rate, column temperature, etc. The separation was performed by using an Inertsil ODS C18 column (250 mm x 4.6 mm, 5μ) and UV absorption was measured at 231 nm. Methanol: Acetonitrile: Water was selected as the mobile phase in the ratio of 50:20:30 (V/V/V) at a flow rate of 1 mL/min. As per International Conference on Harmonization (ICH) Q2 R1 guidelines, several validation parameters were evaluated which include specificity, linearity, precision, accuracy, the limit of detection (LOD), and the limit of quantitation (LOQ).

Results: The acceptable degree of linearity range was found to be 40-100 μg/mL. The standard solution exhibited retention times of 3.06 minutes and 5.07 minutes for Tenofovir and Emtricitabine respectively. The LOD and LOQ obtained were 0.05 μg/ml and 0.02 μg/mL, 15 μg/mL, and 0.08 μg/mL for Tenofovir and Emtricitabine respectively. The percent recovery was found to be 98 to 102%.

Conclusion: Hence, the proposed method is simple, selective, and specifically meets the requirements of ICH guidelines for the validation of the analytical method.

« Previous
Graphical Abstract

[1]
Bhavsar DS, Patel BN, Patel CN. RP-HPLC method for simultaneous estimation of tenofovir disoproxil fumarate, lamivudine, and efavirenz in combined tablet dosage form. Pharm Methods 2012; 3(2): 73-8.
[http://dx.doi.org/10.4103/2229-4708.103876] [PMID: 23781482]
[2]
Vidya DS, Chowdary YA, Murthy TEGK. Development and validation of rp-hplc method for simultaneous estimation of Tenofovir disoproxil fumerate and Efavirenz in bulk and formulation. Int J Pharm Sci Res 2013; 4(12): 4619-24.
[3]
Reddy AP, Teja UC, Sultana SKA, Vijayalakshmi M, Nalluri BN. Development and validation of RP-HPLC method for the simultaneous estimation of emtricitabine, tenofovir disoproxil fumarate and rilpivirine hydrochloride in bulk, pharmaceutical dosage Forms and in dissolution Samples. Indo Amer J Pharm Res 2014; 4(11): 5226-34.
[4]
Gomes NA, Vaidya VV, Pudage A, Joshi SS, Parekh SA. Liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence study. J Pharm Biomed Anal 2008; 48(3): 918-26.
[http://dx.doi.org/10.1016/j.jpba.2008.07.022] [PMID: 18783908]
[5]
Delahunty T, Bushman L, Robbins B, Fletcher CV. The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877(20-21): 1907-14.
[http://dx.doi.org/10.1016/j.jchromb.2009.05.029] [PMID: 19493710]
[6]
Rezk NL, Crutchley RD, Kashuba ADM. Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 822(1-2): 201-8.
[http://dx.doi.org/10.1016/j.jchromb.2005.06.019] [PMID: 16005269]
[7]
Kumar VK. Estimation of Emtricitabine in tablet dosage form by RP-HPLC. Asian J Chem 2009; 21(8): 5979-83.
[8]
Brown RP. Reversed-phase high-performance liquid chromatography, theory, practice and biomedical applications. Krstulovid AM, Brown PR, Eds John Wiley and Sons. 1982; p. 10-20.
[http://dx.doi.org/10.1080/00327488208065683]
[9]
Karunakaran A, Kamarajan K, Thangarasu V. Simultaneous determination of emtricitabine and tenofovir disoproxil fumerate in tablet dosage form by UV-spectrophotometry. Asian J Chem 2011; 23(6): 2719-21.
[10]
Nagaraju PT, Channabasavaraj KP, Shantha Kumar PT. Development and validation of spectrophotometric method for estimation of Emtricitabine in tablet dosage form. Int J Chemtech Res 2011; 3(1): 23-8.
[11]
Valli PB, Reddy VB, Suneetha Y, Ramachandran D. Simultanious determination of antiretroviral drugs Emtricitabine and Tenofovir desoproxil fumerate by a stability indicating RP-HPLC method. Int J Pharm Pharm Sci 2015; 7(9): 390-8.
[12]
Methodology. ICH Harmonized Tripartite Guidelines 1996; (November): 1-8.
[13]
Q2A, Text on Validation of Analytical Procedures International Conference on Harmonization. Geneva. 1994; pp. 1-5.
[14]
Q2B, Validation of Analytical Procedures: Methodology International Conference on Harmonization. Geneva. 1996; pp. 1-8.
[15]
Kavitha KY, Geetha G, Hariprasad R, Venkatnarayana R, Kaviarasu M. Development and validation of stability indicating RP-HPLC method for the simultaneous estimation of linagliptin and metformin in pure and pharmaceutical dosage form. Int Res J Pharm 2013; 5(1): 230-5.
[16]
Venkatesh M, Sumanth ALMN, Rao V, Asian J. A stability-indicating capillary electrophoresis method for the determination of emtricitabine and tenofovir disoproxil fumarate in pharmaceutical tablets. Pharm Ana Med Chem 2013; 1(2): 60-9.
[17]
Ashwini S, Mali P, Salunke A, Barhate SD, Bari MM. Development and validation of simultaneous rp-hplc method for estimation of tenofovir and lamivudine in bulk and pharmaceutical formulations. World J Pharm Res 2015; 4(3): 995-1006.
[18]
Connors KA. A Textbook of Pharmaceutical Analysis. Hoboken, New Jersey, US: Jhon Wiley and Sons 1999; pp. 196-8.
[19]
Sethi PD. Sethi’s HPLC high performance liquid chromatography: Quantitative analysis of pharmaceutical formulations. New Dehli. CBS Publishers and Distributors Pvt Ltd 2012.
[20]
Willard RH, Merritt LL, Dean LA, Settle FA. Instrumental methods of analysis. New Dehli. CBS Publishers and Distributors Pvt Ltd 1986.
[21]
Khaleel N, Rahaman A. A validated stability indicating RP-HPLC method for simultaneous estimation of Tenofovir disoproxil fumarate, Cobicistat, Emtricitabine and Elvitegravir in bulk and pharmaceutical dosage form. Int J Pharm 2015; 5(3): 991-1002.
[22]
Nikalje AP, Shahed M, Dehghan M, Joshi M. HPTLC method for the simultaneous estimation of emtricitabine and tenofovir in tablet dosage form. Indian J Pharm Sci 2009; 71(1): 95-7.
[http://dx.doi.org/10.4103/0250-474X.51951] [PMID: 20177471]
[23]
Malipatil SM, Nandedkar MA. Determination of tenofovir disoproxil fumarate by a sensitive simple isocratic RP-HPLC method. J Ind Coun Chem 2009; 26(1): 67-9.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy